- Home
- OCFC vs MLTX Comparison
OCFC vs MLTX Comparison
Compare OCFC & MLTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | OCFC | MLTX |
|---|---|---|
| Founded | 1902 | 2021 |
| Country | United States | Switzerland |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 972.7M |
| IPO Year | 1996 | N/A |
Fundamental Metrics
Financial Performance| Metric | OCFC | MLTX |
|---|---|---|
| Price | $19.72 | $13.87 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 4 | 9 |
| Target Price | $21.50 | ★ $36.33 |
| AVG Volume (30 Days) | 310.1K | ★ 1.8M |
| Earning Date | 01-22-2026 | 11-05-2025 |
| Dividend Yield | ★ 4.05% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.30 | N/A |
| Revenue | ★ $378,558,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $12.51 | N/A |
| P/E Ratio | $15.19 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $14.29 | $5.95 |
| 52 Week High | $20.61 | $62.75 |
Technical Indicators
Market Signals| Indicator | OCFC | MLTX |
|---|---|---|
| Relative Strength Index (RSI) | 55.05 | 49.48 |
| Support Level | $19.97 | $13.32 |
| Resistance Level | $20.61 | $15.40 |
| Average True Range (ATR) | 0.49 | 0.77 |
| MACD | -0.06 | -0.05 |
| Stochastic Oscillator | 42.58 | 31.64 |
Price Performance
Historical ComparisonAbout OCFC OceanFirst Financial Corp.
OceanFirst Financial Corp is engaged in the banking sector of the United States. It conducts the business of attracting retail and business deposits and investing them in loans, consisting of single-family, owner-occupied residential mortgage loans, and commercial real estate loans. The company's sole segment deals with the delivery of loan and deposit products to customers. The bank's revenues are derived principally from interest on its loans, and to a lesser extent, interest on its investment and mortgage-backed securities. The rest of its income is dependent on bank card services and wealth management products and services.
About MLTX MoonLake Immunotherapeutics
MoonLake Immunotherapeutics is a clinical-stage biotechnology company advancing therapies to address unmet needs in inflammatory skin and joint diseases. The company is focused on the development of SLK, a novel tri-specific IL-17A and IL-17F inhibiting Nanobody that has the potential, based on response levels seen in clinical trials, to drive disease modification in dermatology and rheumatology patients.